RxAll Inc. is a health information technology/big data startup company. The company works with drug regulatory agencies and other stakeholders[1] to reduce fake medicines ensure that patients receive and have better access to high quality verified drugs.

RxAll Inc.
Company typePrivate
IndustryMedical Technology
FoundedJanuary 1, 2016; 8 years ago (2016-01-01)
Headquarters165 Whitney Avenue, New Haven, Connecticut 06520, United States.
Area served
Worldwide
Key people
Adebayo Alonge
(founder / CEO)
Amy Kao
(Co-founder / CMO)
Wei Liu
(Co-founder / CTO)
ProductsMedical Devices
Total equity3.3 Million US dollar.
Websitewww.rxall.net/about-us
rxalldelivered.com

Founding history

edit

RxAll Inc. was established on January 1, 2016, by Yale University - Yale School of Management graduate students Adebayo Alonge, Amy Kao and Wei Liu.[2][3] It is seen as an important weapon against illegal pharmaceutical outfits in Kenya.[4] Alonge was nearly killed by fake salbutamol tablets in Nigeria in 2005.[5]

Early challenges

edit

Like many start-ups, RxAll Inc. came up against early challenges[6] when it almost ran out of cash in the first quarter of 2017, the founding team persisted to raise funds in parallel to operating the business.[7] Co-founders Adebayo Alonge and Amy Kao managed to raise about $1 million in grants and bootstrapped funds from the Nigerian government, the Yale start-up ecosystem, Merck, Villgro and other support networks.[citation needed]

Products

edit

The company's products are:

RxScanner

edit

RxScanner is an handheld drug authenticator device created for patients to verify their drugs and help drug regulators to reduce administrative burden, improve record keeping and also improved productivity and successful prosecution of bad actors.[8] The device is in use by country FDAs, Hospitals, Pharmacies and Big Pharma across the world.[9]

RxAll POS

edit

RxAll POS is a Point of sale software created for Pharmacies in growth market that[10] enables complete automation of the pharmacy management system.

RxAll Delivered

edit

RxAll Delivered is a drug delivery platform that enable pharmacies and patients order verified drugs online for offline delivery at wholesale prices.[11][12]

The company gained market entry into East Africa (Kenya and Uganda), West Africa (Nigeria and Ghana), Southeast Asia (Myanmar, Malaysia and Singapore), and the Americas (Canada, United States and Colombia).[13]

Award

edit

RxAll Inc. won the 2019 BNP Paribas group deep tech award otherwise known as Hello Tomorrow, a competition crafted for tech innovators and entrepreneurs, worth €100,000.[14]

edit

References

edit
  1. ^ "RxAll Inc. Making giant stride". How we made it in Africa. 2017-10-19.
  2. ^ "RxAll Inc. signs MOU with CTI Africa". Medium. 2018-07-23. Retrieved 2020-01-26.
  3. ^ Anzilotti, Ellie (25 March 2019). "This startup built a device to figure out if prescription drugs are fake". Fast Company.
  4. ^ "How Advances in Tech Are Battling the Fake Meds Epidemic (In Kenya)". Nairobi Wire. 24 January 2020. Retrieved 8 February 2020.
  5. ^ "Fighting fake medicines". Chemistry World. 16 May 2019. Retrieved 8 February 2020.
  6. ^ "Startup Saves Lives by Ridding African Market of Counterfeit Drugs". Yale School of Management. 2018-04-06. Retrieved 2020-06-21.
  7. ^ Xiong, Amy (6 April 2018). "New startup targets fake drugs". yaledailynews.com. Retrieved 2020-06-21.
  8. ^ "RxAll, Founded by Adebayo Alonge '16, Named Best Early-Stage Startup in Hello Tomorrow Global Challenge". Yale School of Management. 2019-03-21. Retrieved 2020-01-26.
  9. ^ "RxAll Inc". F6S. Retrieved 2020-01-26.
  10. ^ "RxAll Inc". Innovator's Edge. Retrieved 2020-01-26.
  11. ^ "Opinion: How social enterprises are playing a role in COVID-19 response". Devex. 2020-05-06. Retrieved 2020-06-21.
  12. ^ "Opinion: How social enterprises are playing a role in COVID-19 response". Devex. 2020-05-06. Retrieved 2020-08-07.
  13. ^ "Fight the fakes: how to beat the $200bn medicine counterfeiters". Guardian. 5 June 2019. Retrieved 11 February 2020.
  14. ^ "For His Anti-Fake Drugs Startup, Nigerian Pharmacist Bayo Alonge Beats 4,500 From 119 Countries To Win €100,000 Prize". Sahara Reporters. 21 March 2019. Retrieved 11 February 2020.